Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.

The American journal of pathology·2023
Same author

Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics.

Diagnostics (Basel, Switzerland)·2023
Same author

Clinical Utility of Pancreatic Cancer Circulating Tumor DNA in Predicting Disease Progression, Prognosis, and Response to Chemotherapy.

Pancreas·2020
Same author

Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment.

PloS one·2019
Same author

Recent Advances in Liquid Biopsy in Precision Oncology Research.

Biological & pharmaceutical bulletin·2019
Same author

High-throughput screening in colorectal cancer tissue-originated spheroids.

Cancer science·2018
Same journal

Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Breast cancer (Tokyo, Japan)·2026
Same journal

Functional characterization of BRCA2 variants of uncertain significance identified in Korean breast cancer patients.

Breast cancer (Tokyo, Japan)·2026
Same journal

Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.

Breast cancer (Tokyo, Japan)·2026
Same journal

Prognostic impact of radiotherapy dose to the axilla in cN + /ypN0 breast cancer after primary systemic therapy and sentinel lymph node biopsy: toward true de-escalation of axillary management.

Breast cancer (Tokyo, Japan)·2026
Same journal

Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study.

Breast cancer (Tokyo, Japan)·2026
Same journal

Prognostic impact of progesterone receptor status in patients with breast cancer and isolated locoregional recurrence.

Breast cancer (Tokyo, Japan)·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Algorithm for in vitro diagnostic multivariate index assay.

Kikuya Kato1

  • 1Research Institute, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan. katou-ki@mc.pref.osaka.jp

Breast Cancer (Tokyo, Japan)
|July 9, 2009
PubMed
Summary
This summary is machine-generated.

New gene expression profiling tools, like MammaPrint and Oncotype-DX, are transforming breast cancer diagnostics. These in vitro diagnostic multivariate index assays (IVDMIA) use algorithms to calculate scores for improved patient group classification.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
12:19

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

Related Experiment Videos

Last Updated: Jun 21, 2026

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
08:05

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
12:19

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Biotechnology

Background:

  • Emerging diagnostic tools like MammaPrint and Oncotype-DX are influencing breast cancer clinical practice.
  • These tools utilize gene expression profiling, analyzing numerous genes to generate diagnostic scores.
  • The Food and Drug Administration (FDA) established a new category, in vitro diagnostic multivariate index assay (IVDMIA), for these multi-gene assays.

Purpose of the Study:

  • To explain the methodology and significance of in vitro diagnostic multivariate index assays (IVDMIA) in cancer diagnostics.
  • To highlight the role of algorithms, specifically linear classifiers, in calculating diagnostic scores from gene expression data.
  • To discuss the application and future potential of IVDMIA in breast cancer and other malignancies.

Main Methods:

  • Gene expression analysis of a large number of genes.
  • Development and application of algorithms, primarily linear classifiers, for diagnostic score calculation.
  • Utilizing dimension reduction techniques to interpret high-dimensional gene expression data.

Main Results:

  • IVDMIA tools provide a calculated score based on the expression of multiple genes.
  • Linear classifiers create an (n-1)-dimensional plane in n-dimensional space to differentiate patient groups.
  • The diagnostic score is derived through a process of dimension reduction.

Conclusions:

  • In vitro diagnostic multivariate index assays (IVDMIA) represent a significant advancement in molecular diagnostics.
  • The use of algorithms is crucial for interpreting complex gene expression data in IVDMIA.
  • IVDMIA, currently focused on gene expression profiling, holds promise for diagnosing various cancers beyond breast cancer.